FOXA1 has been reported to inhibit neuroendocrine differentiation of prostate adenocarcinoma, based on the observations that FOXA1 is downregulated in NEPC and that FOXA1 knock-down induces neuroendocrine features in PRAD cell lines30. Here, FOXA1 is linked to prostate adenocarcinoma.